Merkaptopurin Silver (Mercaptopurine Monohydrate)

Mercaptopurine is taken up by cells and metabolized into thio‑guanine nucleotides. These metabolites inhibit the enzyme amidophosphoribosyltransferase, blocking de novo synthesis of purine nucleotides, and they become incorporated into DNA and RNA. The resulting disruption of nucleic acid synthesis leads to cytotoxicity in rapidly dividing cells, including malignant leukemic cells, while also dampening immune cell activity, providing both antineoplastic and immunosuppressive effects.

The dosage of Merkaptopurin Silver is individualized by the prescribing clinician based on the patient’s age, weight, disease indication, and laboratory parameters. Physicians calculate the appropriate dose, often adjusting it according to therapeutic drug monitoring, renal and hepatic function, and tolerance. Patients should follow the exact dosing instructions provided by their healthcare provider and not alter the regimen without medical advice.

The safety of mercaptopurine in pregnancy and lactation has not been definitively established, and it is generally classified as contraindicated unless the potential therapeutic benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative treatment options with their physician, as exposure may be associated with fetal toxicity or neonatal immunosuppression.

To request Merkaptopurin Silver, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing a formal quotation. The sales team then replies with pricing, availability, shipping details—including any temperature‑controlled logistics if needed—and assists with the necessary import documentation.

Both mercaptopurine and azathioprine belong to the thiopurine class and share similar mechanisms of inhibiting purine synthesis. Mercaptopurine is the active metabolite of azathioprine, offering a more direct pharmacologic effect. Clinically, dosing strategies differ, and mercaptopurine may provide more predictable plasma levels, whereas azathioprine requires conversion. Choice between them depends on disease indication, patient tolerance, and physician preference.

Merkaptopurin Silver should be stored at room temperature, preferably below 25 °C (77 °F). Keep the product in its original packaging to protect it from moisture, light, and excessive heat. Do not refrigerate or freeze the tablets, and ensure the container remains tightly closed when not in use to maintain stability throughout its shelf life.

Merkaptopurin Silver is administered orally, typically as a tablet taken with water. The medication may be taken with or without food, depending on the prescriber’s guidance. Patients should swallow the tablet whole and avoid crushing or chewing it unless specifically instructed. Consistent timing each day helps maintain stable drug levels, and adherence to the prescribed schedule is essential for therapeutic effectiveness.

The most serious adverse risks include severe myelosuppression leading to neutropenia or pancytopenia, which can increase susceptibility to infections and bleeding; hepatotoxicity presenting as marked liver enzyme elevation or liver failure; and the rare possibility of secondary malignancies such as lymphomas. Prompt monitoring of blood counts and liver function, along with immediate medical attention for signs of infection or liver injury, is critical.

Merkaptopurin Silver is contraindicated in individuals with known hypersensitivity to mercaptopurine or any component of the formulation. Patients with severe hepatic or renal impairment, active uncontrolled infections, or those receiving other myelosuppressive agents without close monitoring should avoid the drug. Additionally, pregnant or breastfeeding women should not use it unless the prescribing physician determines that the therapeutic benefit outweighs the potential risks.